Thymosin Alpha-1
Immune Modulation
Also known as: Tα1, Zadaxin
A 28-amino acid peptide that enhances immune function by stimulating T-cell maturation and modulating cytokine production.
- Dose in studies
- 1.6-3.2 mg 2-3x weekly
- Frequency
- 2-3x weekly
- Cycle length
- 4-12 weeks based on indication
- Half-life
- 2-3 hours
- Research level
- 4/5 – Well researched
Frequently asked questions about Thymosin Alpha-1
What is Thymosin Alpha-1?
A 28-amino acid peptide that enhances immune function by stimulating T-cell maturation and modulating cytokine production.
What is the half-life of Thymosin Alpha-1?
The half-life of Thymosin Alpha-1 is 2-3 hours.
What dosage of Thymosin Alpha-1 has been studied?
Described in research: 1.6-3.2 mg 2-3x weekly, frequency: 2-3x weekly. This is not a medical recommendation.
How long is a Thymosin Alpha-1 cycle?
Typical cycle length in studies: 4-12 weeks based on indication.
What are the side effects of Thymosin Alpha-1?
Injection site reactions: Mild redness, swelling, or tenderness at injection site. The most commonly reported side effect. Proper site rotation minimizes this. · Fatigue: Temporary tiredness in the first few days as the immune system activates. Similar to the mild fatigue after vaccination. · Low-grade fever: Mild temperature elevation (< 38°C/100.4°F) as immune activation occurs. A sign the…
How well researched is Thymosin Alpha-1?
Well researched (4/5). Large phase 3 trials or regulatory approval; long-term data still limited.